Introduction
============

Numerous studies have demonstrated that reactive oxygen species (ROS) may cause aging \[[@B1]\] and diseases such as malignant neoplasm \[[@B2]\], Alzheimer's disease \[[@B3]\], cataracts \[[@B4]\] and cardiac dysfunction \[[@B5]\]. Hydrogen peroxide that can be converted to HO· is removed by intracellular enzymes such as catalase and glutathione peroxidase (GPx). GPx catalyzes the elimination reaction of H~2~O~2~ using reduced glutathione (GSH). Large quantities of GSH, an antioxidant, are found in organisms that eliminate ROS by enzymatic or non-enzymatic mechanisms. In contrast, the heart has low activity of GPx and catalase and an overall lower GSH content as compared with other organs \[[@B6]\], suggesting that the heart is more sensitive to ROS. Indeed, it has been demonstrated that ischemia-reperfusion leading to an increase in ROS levels results in cardiac contractile dysfunction \[[@B7], [@B8]\]. Administration of L-buthionine-sulfoximine (BSO) which blocks GSH biosynthesis to diabetic rats increases cardiac cell death \[[@B9]\]. These findings suggest that when the generation of ROS exceeds the elimination of it, excess ROS can impair normal biological functions.

There are numerous studies that various stimuli cause myocardial cell death and hypertrophy. Takemoto *et al.* \[[@B10]\] demonstrated that angiotensin II (Ang II) results in the generation of ROS through NADPH oxidase activation and the induction of hypertrophy in neonatal rat cardiomyocytes. Grishko *et al.* \[[@B11]\] observed that Ang II-induced apoptosis and the cell death are inhibited by an NADPH oxidase inhibitor in neonatal cardiomyocytes. In adult rat ventricular myocytes, β-adrenergic receptor stimulation by norepinephrin induces apoptosis mediated by the ROS/c-Jun *N*-terminal kinase (JNK)-dependent mitochondrial death pathway \[[@B12]\]. In addition, norepinephrin also induces hypertrophy in H9c2 cells, a cardiomyocyte cell line derived from rat ventricles \[[@B13]\]. These findings imply that ROS are associated with cell death and/or hypertrophy in cardiomyocytes. It is demonstrated that cyclic mechanical stretching of neonatal rat ventricular myocytes generates superoxide anion radical (O~2~^·−^) that induces hypertrophy and/or cell death depending on the stretch levels \[[@B14]\]. Chen *et al.* \[[@B15]\] demonstrated that a fraction of cells undergoes apoptosis at low concentrations of added H~2~O~2~ and the surviving cells develop hypertrophy, whereas high dose of H~2~O~2~ causes necrosis in H9c2 cells and primary cultured neonatal rat cardiomyocytes. These findings suggest the possibility that differences in intracellular ROS levels can trigger the decision between hypertrophy and cell death in cardiomyocytes.

In the present study, we investigated the relationship between ROS levels and hypertrophy or cell death in H9c2 cardiomyocytes after the addition of H~2~O~2~. Here, we propose that the development of hypertrophy might not be connected with the levels of intracellular ROS, but death is, after the addition of H~2~O~2~ to H9c2 cells.

Materials and Methods
=====================

Chemicals
---------

BSO, deferoxamine (DFX), Dulbecco's modified Eagle's medium (DMEM), pifithrin-α (PFT) and Trolox were obtained from SIGMA Chemical Co. (St. Louis, MO). A florescent probe 2\',7\'-dichlorofluorescin diacetate (DCFH~2~-DA) was purchased from CALBIOCHEM (San Diego, CA). Trypsin-EDTA was obtained from Invitrogen (Grand Island, NY). Phosphate-buffered saline (PBS) was obtained from TAKARA BIO INC. (Tokyo, Japan). H~2~O~2~ was obtained from Kanto Chemical Co. Inc. (Tokyo, Japan). Fetal bovine serum (FBS) was purchased from BIOSOURCE Inc. (Camarillo, CA). The 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay kit was obtained from Promega (Madison, WI). All other chemicals used in this study were of the highest grade available from commercial suppliers.

Cell culture
------------

Rat cardiomyocyte H9c2 cells were obtained from the American Type Culture Collection (Rockville, MD) and were grown in DMEM containing 10% heat-inactivated FBS in an incubator in an atmosphere of 5% CO~2~, 95% air at 37°C. The standard treatments for H9c2 cells were as follows: the cells were seeded onto 6-well plates at a density of 3 × 10^5^ cells/well containing 3 ml culture medium. After an overnight preincubation with or without 0.1 mM BSO, we refer to BSO-untreated cells as normal cells, the cells were incubated with H~2~O~2~ for various time periods at the concentrations indicated in the figure legends. Cell number was measured using a hemocytometer (Erma, Tokyo, Japan). After removal of the medium, the cells were washed once in PBS and once in culture medium before trypsinization. The cells were resuspended with culture medium and washed twice with PBS by centrifugation at 300 × *g* for 5 min. The cell pellets were resuspended with PBS and the cell number was determined.

Cell viability
--------------

Cell viability was determined using an MTT assay kit. After incubation with H~2~O~2~, the medium was removed. For the MTT assay, fresh culture medium (1725 µl) containing a dye solution (225 µl) was added to each of the wells containing cells and incubated for 2 h at 37°C. A solubilization/stop solution (1500 µl) was then added for an additional overnight incubation. The absorbance at 540 nm (formation of formazan) and 690 nm (reference) were recorded with a microplate reader (Labsystems Multiskan Bichromatic, Helsinki, Finland). Viability was determined as compared to control cells (normal H9c2 cells incubated without H~2~O~2~).

Measurement of ROS levels
-------------------------

Intracellular ROS levels were assessed using DCFH~2~-DA \[[@B16]\]. Cells were preincubated with DCFH~2~-DA in the culture medium at a final concentration of 10 µM for 15 min. Following incubation with H~2~O~2~ for 15 min, the cells were trypsinized, collected and washed with PBS by centrifugation at 300 × *g*for 5 min. The cell pellets were resuspended with PBS (1 ml) and analyzed using a flow cytometer (Beckman Coulter, Fullerton, CA). The cells (5 × 10^3^ cells) were screened and the fluorescence of DCF was detected by fluorescence channel 1. The relative intensity of DCF fluorescence was determined as compared to control cells.

Measurement of cell size
------------------------

Relative change in cell size was observed using a flow cytometer. After incubation with H~2~O~2~ for 72 h, the medium was removed from the cultures and the cells were washed once in PBS and once in culture medium before trypsinization. The cells were collected and washed with PBS by centrifugation at 300 × *g* for 5 min. The cell pellets were resuspended with PBS (1--2 ml) and analyzed using a flow cytometer. The cells (1 × 10^4^ cells) were screened and the forward light scatter (FS) and side light scatter (SS) were recorded for each cell to determine the relative size and density, respectively. Control cells were gated so that large sizes were presumed to represent 10% of the cell population (region hypertrophy).

ANP gene expression
-------------------

After incubation with or without H~2~O~2~ for 72 h, total cellular RNA was extracted from H9c2 cells using an illustra RNAspin Mini RNA Isolation kit (GE Healthcare, Tokyo, Japan) according to the manufacturer's instructions, and was quantified by absorbance at 260 nm. RNA (2.5 µg) was reverse transcribed into cDNA using a High-capacity cDNA Reverse Transcription kit (Applied Biosystems, Foster, CA) according to the manufacturer's instructions. TaqMan PCR primer and probe for target gene atrial natriuretic peptide (ANP) and internal standard gene glyceraldehyde-3-phosphate dehydrogenase (GAPDH) were obtained from Applied Biosystems. TaqMan PCR was performed with 1 µl of sample cDNA in a 50-µl reaction mixture containing TaqMan Universal PCR Master Mix using a TaqMan gene expression assay (Applied Biosystems). Amplification was performed using a 7500 real time PCR system (Applied Biosystems). Cycling conditions were 50°C for 2 min, 95°C for 10 min followed by a 50-cycle amplification at 95°C for 15 s and 60°C for 1 min. A threshold cycle number (*C~t~*) at which each PCR amplification reaches a significant threshold level was calculated with the software equipped by the 7500 system. The threshold cycle number is proportional to the number of ANP and GAPDH mRNA copies existing in the reaction mixture. GAPDH was used to normalize mRNA expression. Data were calculated using the ΔΔ*C~t~* method.

Statistical analysis
--------------------

Data are represented as the means ± SD and were statistically analyzed by Student's *t* test or Welch's *t* test following the *F* test for pair data. The value *p*\<0.05 was considered statistically significant.

Results
=======

Effects of H~2~O~2~ on H9c2 cells pretreated with or without BSO
----------------------------------------------------------------

To evaluate oxidative stress, the H9c2 cells were treated with various concentrations of H~2~O~2~. As shown in Fig. [1](#F1){ref-type="fig"}A, the number of normal cells exposed to H~2~O~2~ remained constant during a 72-h incubation period. In BSO-pretreated H9c2 cells, treatment with H~2~O~2~ noticeably decreased the total cell number within 24 h. After the 72-h incubation period, the numbers of normal cells without H~2~O~2~ treatment and BSO-pretreated cells without H~2~O~2~ treatment were about 4.1 and 3.9 times compared with it at 0 h, respectively. The addition of H~2~O~2~ dramatically decreased cell viability after 3 h in H9c2 cells pretreated with BSO (Fig. [1](#F1){ref-type="fig"}B). When BSO-pretreated cells were exposed to H~2~O~2~ at 250 µM or higher for 6 h, the remarkable decrease in cell viability was observed (Fig. [1](#F1){ref-type="fig"}C). In normal cells, however, the decrease of cell viability was barely noticeable at 250 µM, slightly apparent at 500 µM, but remarkably observed at 750 µM of H~2~O~2~. To examine the effect of H~2~O~2~ exposure time on cell death in BSO-pretreated cells, we replaced the medium at various times after the addition of H~2~O~2~. When the medium containing H~2~O~2~ was removed at 5, 15 and 360 min after the addition of H~2~O~2~ (250 µM), cell viabilities were approximately 63, 37 and 33%, respectively (Fig. [1](#F1){ref-type="fig"}D), suggesting that a signal of the cell death developed within 15 min after the addition of H~2~O~2~. We measured the changes of cell size after the addition of H~2~O~2~ using a flow cytometer to assess hypertrophy. FS and SS were recorded to determine the relative size and density of cells, respectively. Normal H9c2 cells not exposed to H~2~O~2~ were gated so that larger cell sizes were 10% of the total cell population (hypertrophic cells). The population of cells that belong to a region of hypertrophy was approximately 30% at 72 h after the addition of H~2~O~2~ (Fig. [1](#F1){ref-type="fig"}E). The expression of ANP gene, a maker of cardiac hypertrophy \[[@B14]\], in normal cells treated with H~2~O~2~ for 72 h, was remarkably increased compared with normal cells without H~2~O~2~ (Fig. [1](#F1){ref-type="fig"}F). We were unable to detect the alteration of cell sizes and gene expression in the BSO-pretreated cells because the substantial decrease in cell viability was caused within 6 h after the addition of H~2~O~2~. These results indicate that H~2~O~2~ induces cell death in BSO-pretreated H9c2 cells and hypertrophy in normal cells.

ROS levels and cell viability in H9c2 cells
-------------------------------------------

The levels of intracellular ROS in H9c2 cells were measured 15 min after the addition of H~2~O~2~ using a fluorescent probe, DCFH~2~-DA (Fig. [2](#F2){ref-type="fig"}). In normal cells exposed to H~2~O~2~, the intensity of DCF fluorescence was slightly increased. In BSO-pretreated H9c2 cells, addition of H~2~O~2~ significantly increased the intensity of DCF fluorescence compared to that obtained in the normal cells (Fig. [2](#F2){ref-type="fig"}), suggesting the increasing generation of ROS resulting from H~2~O~2~ in the GSH-depleted cells. The intensity of DCF fluorescence decreased 15 min or later after H~2~O~2~ treatment and returned to basal levels at 60 min.

To determine whether ROS are associated with cell death, we examined the effect of the antioxidant Trolox on ROS levels and cell viability in H9c2 cells. As shown in Fig. [3](#F3){ref-type="fig"}A, Trolox prevented the increase in intensity of DCF fluorescence in a dose-dependent manner, and very little DCF fluorescence was observed at 50 µM or higher concentrations of Trolox. Trolox also protected H9c2 cells pretreated with BSO from cell death by the addition of H~2~O~2~ in a dose-dependent manner (Fig. [3](#F3){ref-type="fig"}B). Trolox (200 µM) almost completely prevented cell death induced by the addition of H~2~O~2~ in BSO-pretreated cells. Other antioxidants such as butylated hydroxyanisole and butylated hydroxytoluene also prevented the increase in the ROS levels and the death induced after the addition of H~2~O~2~ (data not shown).

We examined the effect of DFX, an iron chelator, on intracellular ROS levels and cell viability, because H~2~O~2~ is converted to HO·, the most highly reactive species of ROS, under biological conditions through the Fenton reaction between H~2~O~2~ and ferrous ion \[[@B2]\]. As shown in Fig. [4](#F4){ref-type="fig"}A, DFX inhibited the increase in DCF fluorescence intensity in a dose-dependent manner, and at 100 µM DFX the increase was no longer observed. DFX also prevented cell death induced by H~2~O~2~ in a dose-dependent manner in cells pretreated with BSO, and completely abolished cell death at 100 µM DFX (Fig. [4](#F4){ref-type="fig"}B). These results indicate that the increase in ROS levels is associated with the cell death in BSO-pretreated H9c2 cells after the addition of H~2~O~2~.

Relationship between hypertrophy and ROS levels
-----------------------------------------------

To determine whether ROS is associated with the cell hypertrophy induced by the addition of H~2~O~2~, we examined the effects of Trolox and DFX on hypertrophy in normal cells. In the presence of Trolox, the percentage of the population of normal cells belonging to a region of hypertrophy was approximately 42% at 72 h after the addition of H~2~O~2~, but that of cells without H~2~O~2~ treatment was about 11% (Fig. [5](#F5){ref-type="fig"}A). When the cells were incubated with DFX alone for 72 h, cell death was observed (data not shown). To remove the toxic effect of DFX, the medium containing DFX was exchanged for fresh medium 3 h after the addition of H~2~O~2~. After incubation with DFX, the percentage of the normal cell population belonging to a region of hypertrophy was approximately 28% at 72 h after the addition of H~2~O~2~, although the fraction of hypertrophic cells without exposure to H~2~O~2~ was approximately 12% (Fig. [5](#F5){ref-type="fig"}B). After incubation with Trolox or DFX, the fraction of BSO-pretreated cells belonging to a region of hypertrophy was approximately 35% or 33%, respectively, 72 h after the addition of H~2~O~2~; that of cells without H~2~O~2~ was about 10% in both cases (Fig. [5](#F5){ref-type="fig"}B). In cells pretreated with (Figs. [3](#F3){ref-type="fig"}A and [4](#F4){ref-type="fig"}A) or without (Fig. [5](#F5){ref-type="fig"}C) BSO, the intensity of DCF fluorescence observed after the addition of H~2~O~2~ in the presence of Trolox or DFX was lower than the basal intensity in normal cells incubated without H~2~O~2~. These results indicated that cell hypertrophy is induced even when intracellular ROS levels do not increase after the addition of H~2~O~2~.

Because several studies have demonstrated that the addition of H~2~O~2~ induces activation of p53 protein and then cell death \[[@B17]--[@B19]\], we examined the effect of PFT, an inhibitor of p53 \[[@B20], [@B21]\], on the death and ROS levels in cells incubated with H~2~O~2~. PFT prevented cell death induced by H~2~O~2~ in BSO-pretreated H9c2 cells and cell viability was approximately 76% in the presence of PFT (Fig. [6](#F6){ref-type="fig"}A). PFT did not significantly affect the increase in DCF fluorescence intensity after the addition of H~2~O~2~ (Fig. [6](#F6){ref-type="fig"}B). These data indicate that PFT inhibits cell death without significantly influencing the ROS levels after the addition of H~2~O~2~ in BSO-pretreated H9c2 cells. We examined whether hypertrophy is induced in the presence of PFT where ROS levels are remarkably increased after the addition of H~2~O~2~. As shown in Fig. [6](#F6){ref-type="fig"}C, the fraction of the population of cells belonging to a region of hypertrophy increased (approximately 38%) in the presence of PFT at 72 h after the addition of H~2~O~2~. PFT itself had no effect on the cell size and viability of normal (data not shown) and BSO-pretreated cells in the absence of H~2~O~2~ (Fig. [6](#F6){ref-type="fig"}C). We found that the development of hypertrophy might not be connected with the levels of intracellular ROS after the addition of H~2~O~2~ in H9c2 cells.

Discussion
==========

We demonstrated that the addition of H~2~O~2~ induces cell hypertrophy in normal H9c2 cells and cell death in BSO-pretreated H9c2 cells. BSO would deteriorate the ability of H9c2 cells to scavenge ROS, because BSO inhibits *de novo* synthesis of GSH, a key compound playing roles in the function to prevent accumulation of ROS, and then results in lower amounts of intracellular GSH \[[@B6], [@B22]\]. A remarkable increase in intracellular ROS generation was observed after the addition of H~2~O~2~ in BSO-pretreated cells as compared with normal cells (Fig. [2](#F2){ref-type="fig"}). Trolox and DFX significantly prevented the increase in intracellular ROS generation and cell death by the addition of H~2~O~2~ in BSO-pretreated H9c2 cells (Figs. 3 and [4](#F4){ref-type="fig"}).

We showed that normal H9c2 cells exhibited a slight increase in intracellular ROS levels followed by cell hypertrophy upon the addition of H~2~O~2~ (Figs. [1](#F1){ref-type="fig"} and [2](#F2){ref-type="fig"}). Kwon*et al.* \[[@B23]\] and Chen *et al.* \[[@B15]\] proposed that H~2~O~2~-treatement at a low concentration induces cell hypertrophy. Pimentel *et al.* \[[@B14]\] demonstrated that mechanical stretching of neonatal rat ventricular myocytes, which generates O~2~^·−^, induces hypertrophy and/or cell death, depending on the stretch levels. These results indicate the possibility that low levels of ROS induce hypertrophy and high levels of ROS induce cell death. In the present study, we also observed that cell death induced by the addition of H~2~O~2~ was prevented by an inhibitor of p53, PFT, in BSO-pretreated H9c2 cells. L'Ecuyer *et al.* \[[@B21]\] demonstrated that H~2~O~2~-treatment induces DNA injury in H9c2 cells. DNA damage activates p53, which mediates cell death in many types of cells containing cardiomyocytes. From these findings, we speculate that PFT inhibited the cell death as a consequence of inhibiting p53 function, although the detailed mechanism of H~2~O~2~ cytotoxicity is not clearly understood. Prevention of H~2~O~2~-induced cell death by PFT led to hypertrophy in BSO-pretreated H9c2 cells though levels of intracellular ROS dramatically increased (Fig. [6](#F6){ref-type="fig"}). In contrast, the addition of H~2~O~2~ induced cell hypertrophy even when Trolox and DFX lowered the ROS levels below basal levels in both H9c2 cells pretreated with or without BSO (Figs. [3](#F3){ref-type="fig"}--[5](#F5){ref-type="fig"}). From these findings, we conclude that the development of hypertrophy might not be connected with the levels of intracellular ROS after the addition of H~2~O~2~ to H9c2 cells.

In the presence of Trolox or DFX, the intensity of DCF fluorescence was not increased in H9c2 cells after the addition of H~2~O~2~, implying a possibility that the added H~2~O~2~ itself did not induce or hardly induced the increase in DCF-fluorescence as compared with other oxygen species such as O~2~^·−^ and HO^·^. Trolox is a cell-permeable, water-soluble derivative of vitamin E and can scavenge free radicals such as O^·−^ and HO^·^ \[[@B24]\]. In line with other studies that the oxidation of DCFH~2~ by H~2~O~2~ requires mediation by a catalyst such as peroxidase in cell free system \[[@B25], [@B26]\], we have also confirmed that H~2~O~2~ itself doesn't directly oxidize DCFH~2~. DCF fluorescence may reflect generated HO^·^ in the present experiment system, because DFX, that is able to lower the levels of intracellular free iron and inhibit the Fenton reaction \[[@B2], [@B27]\], suppressed the increase in DCF fluorescence intensity in H9c2 cells after the addition of H~2~O~2~. We have also confirmed that hypertrophy developed in H~2~O~2~-dose dependent manner in H9c2 cells in the presence of Trolox and that catalase inhibited the hypertrophy. From these findings, we hypothesize that H~2~O~2~ itself participates in the induction of hypertrophy in H9c2 cells. The present study would provide a new insight into the hypertrophy in H9c2 cells, a cardiomyocyte cell line, from a standpoint of sensitivity to ROS generated after the addition of H~2~O~2~. To clarify our hypothesis, further studies are needed using primary cultured cardiomyocytes, which should prove the useful information to understand the role of H~2~O~2~ in the development of cardiomyocyte hypertrophy.

Pretreatment with BSO decreased the content of intracellular GSH to 30% as compared with that of normal H9c2 cells \[[@B28]\]. GSH not only plays key roles in the function to prevent accumulation of ROS, but also regulates redox signaling \[[@B29], [@B30]\]. Tanaka *et al.* \[[@B28]\] observed that GSH-depleted H9c2 cells underwent cell hypertrophy after the addition of H~2~O~2~ in the presence of exogenous thiol compounds and also proposed a requirement of thiol for the induction of cell hypertrophy. In the present study, BSO-pretreated H9c2 cells underwent death by the addition of H~2~O~2~, although the treatment of BSO may result in the increase in intracellular cysteine content due to inhibition of γ-glutamylcysteine synthetase. In addition, non-thiol compounds Trolox and DFX inhibited the cell death in BSO-pretreated H9c2 cells after the addition of H~2~O~2~ and these cells underwent hypertrophy. From these findings, we think that GSH, but not cysteine, plays a role of antioxidants and that GSH itself could not be essential for the development of hypertrophy in H9c2 cells exposed to H~2~O~2~.

In the present study, we conclude that H9c2 cardiomyocytes exhibit the differential sensitivity to intracellular ROS generation with regard to hypertrophic versus death responses to exogenously added H~2~O~2~, and propose the possibility that cell hypertrophy is developed independently of intracellular ROS, but cell death is dependent on, in H9c2 cells. The fact that prevention of H~2~O~2~-induced cell death led to the hypertrophy in H9c2 cells suggests a possibility that the prevention of cardiomyocyte death induced by oxidative stress involves a risk of hypertrophy.

Ang II

:   angiotensin II

BSO

:   L-buthionine-sulfoximine

DCFH~2~-DA

:   2\',7\'-dichlorofluorescin diacetate

DFX

:   deferoxamine

DMEM

:   Dulbecco's modified Eagle's medium

GPx

:   glutathione peroxidase

HO·

:   hydroxyl radical

MTT

:   3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide

PBS

:   phosphate-buffered saline

PFT

:   pifithrin-α

ROS

:   reactive oxygen species

O~2~^·−^

:   superoxide anion radical

![Effects of H~2~O~2~ on H9c2 cells pretreated with or without BSO. H9c2 cells were pretreated with (open diamond and closed diamond) or without (open circle and closed circle) BSO. Cells (closed diamond and closed circle) were exposed to H~2~O~2~ (250 µM) and the number of cells (A) and viability (B) were determined at the times indicated in the figures by counting and an MTT assay, respectively. (C) Cell viability 6 h after exposure to different concentrations of H~2~O~2~. (D) Effect of H~2~O~2~ (250 µM) exposure time on viability of the BSO-pretreated H9c2 cells. These data represent the means ± SD of three independent experiments. (E) Size of cells was analyzed using a flow cytometer at 72 h after the addition of H~2~O~2~ (250 µM). FS and SS were recorded for each cell to determine the relative size and density, respectively. Similar results were obtained in two additional independent experiments using different cell preparations. (F) ANP gene expression in normal H9c2 cells at 72 h after the addition of H~2~O~2~ (250 µM). Data represent the means ± SD of three independent experiments. \* *p*\<0.05 compared with H~2~O~2~-untreated normal cells (C and F) and cells pretreated with BSO (D).](jcbn09-47f01){#F1}

![Intracellular ROS levels by the addition of H~2~O~2~ in H9c2 cells. H9c2 cells pretreated with or without BSO were preincubated with DCFH~2~-DA (10 µM) for 15 min prior to the addition of H~2~O~2~. After incubation with H~2~O~2~ (250 µM) for 15 min, the intensity of DCF fluorescence was analyzed using a flow cytometer. Data represent the mean intensities of DCF fluorescence ± SD relative to the DCF fluorescence intensity of the control of seven independent experiments. \* *p*\<0.05 compared with normal cells untreated with H~2~O~2~.](jcbn09-47f02){#F2}

![Effect of Trolox on intracellular ROS levels and viability. The culture medium of H9c2 cells pretreated with BSO (0.1 mM) was replaced by one containing BSO and Trolox (0, 10, 50 or 200 µM) 1 h before the addition of H~2~O~2~ at a final concentration of 250 µM. (A) Levels of intracellular ROS were determined using DCFH~2~-DA at 15 min after the addition of H~2~O~2~. (B) Cell viability 6 h after the addition of H~2~O~2~. Data represent the means ± SD of three independent experiments. \* *p*\<0.05 compared with cells treated with H~2~O~2~ in the absence of Trolox.](jcbn09-47f03){#F3}

![Effect of DFX on intracellular ROS levels and viability. The culture medium of H9c2 cells pretreated with BSO (0.1 mM) was replaced by one containing BSO and DFX (0, 10, 25, 50 or 100 µM) 1 h before the addition of H~2~O~2~ at a final concentration of 250 µM. (A) Levels of intracellular ROS were determined using DCFH~2~-DA at 15 min after the addition of H~2~O~2~. (B) Cell viability 6 h after the addition of H~2~O~2~. Data represent the means ± SD of three independent experiments. \* *p*\<0.05 compared with cells treated with H~2~O~2~ in the absence of DFX.](jcbn09-47f04){#F4}

![Effects of Trolox and DFX on hypertrophy. The culture medium of H9c2 cells was replaced by one containing Trolox (200 µM) or DFX (100 µM) with (B) or without (A) BSO 1 h before the addition of H~2~O~2~ at a final concentration of 250 µM. The size of cells was analyzed 72 h after the addition of H~2~O~2~ using a flow cytometer. FS and SS were recorded for each cell to determine the relative size and density, respectively. The culture medium containing DFX was replaced with the fresh medium 3 h after the addition of H~2~O~2~. Similar results were obtained in two additional independent experiments using different cell preparations. (C) ROS levels obtained 15 min after the addition of H~2~O~2~ in normal cells in the presence or absence of Trolox or DFX. Data represent the means ± SD of three independent experiments. \* *p*\<0.05 compared with normal cells untreated with H~2~O~2~.](jcbn09-47f05){#F5}

![Effects of PFT on ROS levels and hypertrophy. The culture medium of H9c2 cells pretreated with BSO was replaced by one containing BSO and PFT (0, 1, 5 and 20 µM) at 1 h before the addition of H~2~O~2~ at a final concentration of 250 µM. (A) Cell viability 6 h after the addition of H~2~O~2~. (B) Levels of intracellular ROS were determined using DCFH~2~-DA at 15 min after the addition of H~2~O~2~. Data represent the means ± SD of three independent experiments. (C) The size of cells was analyzed 72 h after the addition of H~2~O~2~ using a flow cytometer. Similar results were obtained in two additional independent experiments using different cell preparations. \* *p*\<0.05 compared with cells treated with H~2~O~2~ in the absence of PFT.](jcbn09-47f06){#F6}
